Filing Flows

Filing Flows › Becton Dickinson (BDX) › Recalls, complaints & regulation

Becton Dickinson (BDX): recalls, EPA violations, clinical trials and Federal Register

Becton Dickinson (BDX) beyond its filings: 21 recalls in the last 12 months (149 in five years, 10 Class I); 0 EPA-regulated facilities in violation, $59K in penalties over five years; 1 Federal Register document in a year; 5 active clinical trials.

Latest recalls

Becton Dickinson's latest quarter

Becton Dickinson, Q3 FY26: revenue $5.0B (+5% year over year), operating margin 13.3%, net earnings $377M, operating cash flow $776M. The chart follows the revenue to costs, profit and cash.

Questions

Has Becton Dickinson had any recalls?

149 recalls on file over five years from the FDA, CPSC and NHTSA; 21 in the last 12 months.

Has Becton Dickinson been fined by the EPA?

The 54 EPA-regulated facilities on file under its name drew $59K in penalties over five years; 0 are in violation now.

How many clinical trials does Becton Dickinson have?

5 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.